fashion -WSS

fashion

author：fashion 2025-09-06 05:59:57 - browse：6866

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Senators start work on Medicare physician payment reform

WSS

Diagnostic tests are hitting their mathematical limits

A disappointing year of Humira biosimilars

Medicare Advantage proposed rates disappoint insurers

Organ aging and disease risk measured by new blood test

A disappointing year of Humira biosimilars

Biden report: The neurospychology of memory and aging

knowledge

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

To avoid data mishandling cases, universities eye AI and other tools

Wildfire smoke exposes gaps in outdoor worker protections

UnitedHealth’s Optum accused of antitrust violations in California

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The EPA's new lead rule: How one expert crunched the numbers

Sports medicine is finally prioritizing gender equality

ReNAgade cuts staff seven months after raising $300 million

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: How biotech is using artificial intelligence

explore

Medical mystery: When a cough is not just a cough

Despite FDA concern, risk that CAR

Will the market for weight loss drugs really reach $100 billion?

Medicare threatens to cut off funding for HCA's Mission hospital

Robert F. Kennedy is pitching centrism on health, even on abortion

Vaccine advisory panel ACIP left half staffed by HHS

entertainment

hotspot

Wikipedia

knowledge